Department of Thoracic Surgery and Thoracic Endoscopy, Ruhrlandklinik, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Department of Thoracic Surgery and Thoracic Endoscopy, Ruhrlandklinik, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Ann Thorac Surg. 2019 Jul;108(1):244-248. doi: 10.1016/j.athoracsur.2019.02.030. Epub 2019 Mar 20.
Endobronchial ultrasound-guided transbronchial needle aspirations (EBUS-TBNAs) are well established for staging lung cancer. A growing number of publications report on lymphoma diagnosis via EBUS-TBNA-acquired cytology; however current guidelines recommend histologic diagnosis. Research on the value of EBUS-TBNA-acquired cytology versus surgical-acquired histology in the diagnosis of lymphoma is lacking.
We conducted a retrospective review of patients with mediastinal lymphoma diagnosed between 2010 and 2016. Mediastinal lymphadenopathy was accessible through both EBUS-TBNAs and surgical procedures. All data were extracted from our clinic's medical database and analyzed.
Fifty-one patients newly diagnosed with lymphoma in the mediastinum were identified (median age, 43.5 years; mean age, 48.6 ± 20.6 years). A minimally invasive procedure was performed as a first diagnostic step in 29 patients, whereas surgical biopsy was performed in the remaining 22. The time to final diagnosis was significantly longer if a minimally invasive procedure was performed first compared with a surgical procedure (mean, 44 days [median, 38 days] vs 16 days [median, 8 days]; p < 0.030). The number of procedures to obtain a final diagnosis ranged from one to five (median, 2 procedures per patient) in the EBUS-TBNA group. This was significantly higher than that in the surgical group (median, 1 procedure per patient; p < 0.00005).
We demonstrate that surgical biopsies are safe and well tolerated for lymphoproliferative disease diagnosis and lead to a final diagnosis in the shortest possible time. Unnecessary procedures were significantly reduced if a surgical biopsy was performed as the first step.
经支气管超声引导针吸活检术(EBUS-TBNA)已广泛应用于肺癌分期。越来越多的出版物报道了通过 EBUS-TBNA 获得的细胞学诊断淋巴瘤;然而,目前的指南建议进行组织学诊断。关于 EBUS-TBNA 获得的细胞学与手术获得的组织学在淋巴瘤诊断中的价值的研究尚缺乏。
我们对 2010 年至 2016 年间诊断为纵隔淋巴瘤的患者进行了回顾性研究。纵隔淋巴结病可通过 EBUS-TBNA 和外科手术获得。所有数据均从我们诊所的医疗数据库中提取并进行分析。
共确定了 51 例新诊断的纵隔淋巴瘤患者(中位年龄 43.5 岁;平均年龄 48.6±20.6 岁)。29 例患者首先进行了微创性诊断步骤,而其余 22 例患者则进行了外科活检。与外科活检相比,首先进行微创性诊断步骤时,最终诊断的时间明显延长(平均 44 天[中位数 38 天] vs 16 天[中位数 8 天];p<0.030)。在 EBUS-TBNA 组中,获得最终诊断的操作次数从 1 次到 5 次不等(中位数为 2 次/患者),明显高于外科组(中位数为 1 次/患者;p<0.00005)。
我们证明外科活检是安全的,并且可以很好地耐受用于诊断淋巴增生性疾病,并能在最短的时间内得出最终诊断。如果首先进行外科活检,可显著减少不必要的操作。